Avenzo Therapeutics Advances Dual CDK Inhibitor Breast Cancer Study
SAN DIEGO, Calif., April 28, 2026 Avenzo Therapeutics, Inc. has announced the initiation of the combination cohort in its...
CDK4 Inhibitor
Advertisement
Pfizer Reports Positive Phase 2 Breast Cancer Results
New York, USA | March 17, 2026 Pfizer has announced positive topline results from its Phase 2 FOURLIGHT-1 clinical...
Advertisement
